The iconic rise of Sildenafil presented a massive opportunity for the market, but its exclusivity has expired , creating a challenging landscape. Off-brand versions have entered the arena, eroding revenues and putting pressure on profit margins . While major healthcare companies continue a stake in this area, the potential remains ambiguous by inte